Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer’s disease and type 2 diabetes

BACKGROUND: Both Alzheimer’s disease (AD) and type 2 diabetes (T2D) share common pathological features including inflammation, insulin signaling alterations, or vascular damage. AD has no successful treatment, and the close relationship between both diseases supports the study of antidiabetic drugs...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Hierro-Bujalance, Carmen, Infante-Garcia, Carmen, del Marco, Angel, Herrera, Marta, Carranza-Naval, Maria Jose, Suarez, Javier, Alves-Martinez, Pilar, Lubian-Lopez, Simon, Garcia-Alloza, Monica
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140573/
https://ncbi.nlm.nih.gov/pubmed/32264944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00607-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados